Stay updated on CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Sign up to get notified when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.

Latest updates to the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and notices about government funding were removed; these changes do not affect the study details or outcomes on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedA funding/operational notice banner was added and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and updated the page revision to v3.4.0. Capitalization of labels was standardized (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows Revision: v3.3.4, replacing v3.3.3. This is a non-content UI update and does not affect the study details.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing all study sites across US states, Australia, and Canada, and removed the separate per-location pages (e.g., Arizona Locations, California Locations, etc.).SummaryDifference3%

Stay in the know with updates to CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.